Search
Close this search box.

What is happening at Pivot Park?

News

Search

Categories

News

Pivot Park Screening Centre (PPSC) and Center for Mass Spectrometry and Optical Spectroscopy (CeMOS) form a strategic partnership for joint label-free cellular lead discovery screening services

PPSC and CeMOS have formed a strategic partnership to provide industry-leading joint early drug discovery services, with an emphasis on label-free “cell-based” target-centric, phenotypic, and functional MALDI MS assays for ultra-High-Throughput Screening (uHTS), hit-to-lead biological profiling and in-vitro DMPK/ADME-T.

Read More »
News

Preclinical Drug Discovery in just 5 days

After the success of last year, Radboud University has selected life sciences campus, Pivot Park in Oss, as the backdrop of one of their summer school courses in July 2022. Radboud University teamed up with Pivot Park Screening Centre, and HAN University of Applied Science to organize the summer school course: Introduction to preclinical drug discovery.

Read More »
News

Synaffix Inks Deal with MacroGenics to Enable Next Generation ADCs

Synaffix announced their second deal of 2022 with MacroGenics, Inc. with a potential deal value of up to $586 million, plus royalties on commercial sales. 

MacroGenics will combine its proprietary antibody and bispecific DART® technology with their linker-payload technologies to develop up to three next generation both monospecific and bispecific conjugates.

Read More »
News

Pharming announces positive results of Phase II/III pivotal clinical study of leniolisib for the treatment of activated PI3K delta syndrome

Pharming Group announces positive results from the pivotal Phase II/III blinded randomized, placebo-controlled registration-enabling study of leniolisib for the treatment of activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) also known as PASLI (p110δ-activating mutation causing senescent T cells, lymphadenopathy, and immunodeficiency).

Read More »
10 years Pivot Park

Pivot Park viert tienjarig bestaan

De vlag kan uit op Pivot Park. Op 1 februari is het namelijk precies tien jaar geleden dat de Osse Life Sciences park zijn levenslicht zag. In die periode heeft het bedrijvenpark zich ontwikkeld tot een biofarmaceutische hotspot. Om het jubileum te vieren, staat Pivot Park in 2022 stil bij zijn successen en kijkt het uit naar de toekomst.

Read More »
News

ImmunoPrecise Relocates European Subsidiary to LEED Certified Campus to Continue to Advance its Antibody Research Operations and Environmental Sustainability

“We are very excited to advance our ambitions driving our valuable innovation-driven antibody discovery, selection, engineering, and manufacturing capabilities in our new state-of-the-art facility. We are confident that this expansion enables us to meet the growing interest in IPA’s custom antibody solutions and R&D activities.”

Read More »

Pivot Park Captains' Dinner

10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.

Now it’s time to celebrate!

We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.

Erwin Wurm | Am I a House?

For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?

#100YEARSPHARMAFUTURE

The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.